RNA sequencing analysis feasible for diagnosis of molecular subtypes in pediatric B-ALL Post author: Post published:January 29, 2024 Post category:uncategorized Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases. You Might Also Like EULAR publishes updated recommendations for SLE management December 8, 2023 Foam technology revolutionizes gene therapy, boosting efficiency and safety June 3, 2024 Research highlights depression trends in community-dwelling older adults January 8, 2025